Developing a sudden fever, dry cough, and intense headache after handling a pet bird can be a confusing and worrying experience. Psittacosis, also known as parrot fever, is a bacterial infection caused by Chlamydia psittaci. While it often mimics the flu, the symptoms can linger and disrupt daily life, causing significant fatigue and respiratory discomfort. For some, the infection remains mild, but for others, it can escalate into serious pneumonia.

Treatment is essential to eliminate the bacteria and prevent complications such as heart or liver inflammation. The primary goal is to cure the infection quickly to restore health and prevent the spread of the disease to others. Because the severity of the illness varies, ranging from mild flu-like symptoms to severe respiratory distress, treatment plans are tailored to the individual. Doctors consider age, pregnancy status, and the severity of symptoms when selecting the appropriate medication (Centers for Disease Control and Prevention, 2024).

Overview of treatment options for Psittacosis

The cornerstone of treating psittacosis is antibiotic therapy. Unlike viral infections that must run their course, this condition requires prescription medication to clear the bacteria from the body. Treatment is typically administered on an outpatient basis for mild to moderate cases, allowing patients to recover at home.

For severe cases involving extensive pneumonia or complications, hospitalization may be necessary to provide intravenous antibiotics and oxygen support. While rest and hydration are important lifestyle measures that support recovery, they cannot cure the infection on their own. Pharmacological intervention is the standard and necessary approach to resolve the illness effectively.

Medications used for Psittacosis

The most effective and commonly prescribed class of drugs for psittacosis is tetracycline antibiotics. Specifically, doxycycline is considered the first-line treatment of choice for most adults. Clinical experience suggests that patients typically respond well to this medication, often seeing a reduction in fever and symptom severity within 24 to 48 hours of starting the course.

For patients who cannot take tetracyclines such as pregnant women, children under the age of eight, or those with specific allergies, macrolide antibiotics are the standard second-line option. Azithromycin and erythromycin are the most frequently used alternatives in this class. These medications are effective but may require different dosing schedules compared to tetracyclines.

In addition to antibiotics, over-the-counter antipyretics and analgesics, such as acetaminophen or ibuprofen, are often recommended to manage fever and muscle aches associated with the infection. It is standard practice to continue antibiotic treatment for a period even after the fever disappears to ensure the infection is fully eradicated (Mayo Clinic, 2022).

How these medications work

Antibiotics treat psittacosis by directly targeting the Chlamydia psittaci bacteria. Tetracyclines (like doxycycline) and macrolides (like azithromycin) are bacteriostatic agents. This means they do not instantly kill the bacteria but rather stop them from multiplying.

These drugs work by entering the bacterial cells and binding to their ribosomes—the machinery responsible for building proteins. By blocking protein synthesis, the medication prevents the bacteria from growing and repairing themselves. This halts the spread of the infection and weakens the bacteria enough for the body’s immune system to effectively destroy and remove the remaining pathogens.

Side effects and safety considerations

While generally safe, these antibiotics have well-known side effects. Tetracyclines like doxycycline often cause photosensitivity, meaning the skin becomes much more sensitive to sunlight. Patients are advised to wear sunscreen and protective clothing during treatment. Gastrointestinal issues, such as nausea, vomiting, or diarrhea, are common with both tetracyclines and macrolides.

Safety warnings are specific for certain groups. Tetracyclines are typically avoided in young children and pregnant women because they can affect bone growth and cause permanent discoloration of developing teeth. Macrolides are safer for these groups but can interact with other medications metabolized by the liver. Patients should seek immediate medical care if they experience severe shortness of breath, chest pain, or signs of an allergic reaction like hives or swelling (MedlinePlus, 2021).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Centers for Disease Control and Prevention. https://www.cdc.gov
  2. Mayo Clinic. https://www.mayoclinic.org
  3. MedlinePlus. https://medlineplus.gov
  4. National Organization for Rare Disorders. https://rarediseases.org

Medications for Psittacosis

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Psittacosis.

Found 1 Approved Drug for Psittacosis

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances